Biotech Analyst Brayer, along with Key Opinion Leader Dr. de Jesus Perez of Stanford University and Dr. Zusman of Mass General Hospital discuss PAH treatments in development ahead of Gossamer’s upcoming Phase 2 TORREY Readout on an Analyst/Industry conference call to be held on November 18 at 12 pm. Webcast Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on GOSS:
- Goldman Sachs Says These 2 Buy-Rated Stocks Have at Least 60% Upside Potential
- Street Wrap: Today’s Top 15 Upgrades, Downgrades, Initiations
- Gossamer Bio initiated with a Buy at Goldman Sachs
- Merck data ‘positive read through’ to Gossamer, says Piper Sandler
- Gossamer Bio initiated with Neutral into ‘binary event’ at JPMorgan
